CJC-1295 (WITH DAC) 5MG

CJC-1295 With DAC 5MG | Extended Half-Life GHRH

A long-acting Growth Hormone Releasing Hormone analogue with Drug Affinity Complex for sustained research protocols.

CJC-1295 With DAC is a synthetic peptide designed to study the continuous stimulation of the pituitary gland. The addition of the Drug Affinity Complex (DAC) allows the peptide to bind to serum albumin, significantly extending its half-life to several days. This makes it a primary subject for research into long-term growth hormone elevation and its effects on systemic recovery.

Research Benchmarks: Sustained GH Elevation

• Basal GH Levels: Studying the steady-state increase of growth hormone without significant pulsatile peaks.
• IGF-1 Modulation: Investigating the long-term impact on insulin-like growth factor-1 levels.
• Tissue Repair: Researching the efficacy of sustained GH levels on chronic musculoskeletal injury models.

Scientific Reference Library

• 🧪 Research: Pharmacokinetics of long-acting GHRH analogues
• 🧪 Research: Mechanism of Drug Affinity Complex in peptide stability
• 🧪 Research: Impact of sustained GHRH agonism on the IGF-1 axis